🇺🇸 FDA
Patent

US 10065946

Benzazole compounds and methods for making and using the compounds

granted A61KA61K31/454A61K31/4545

Quick answer

US patent 10065946 (Benzazole compounds and methods for making and using the compounds) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/454, A61K31/4545, A61K31/496, A61K31/5377